7
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T40068 | SENP1-IN-1 | SENP1-IN-1 | |
SENP1-IN-1 is a distinct inhibitor of the deSUMOylation protease 1 (SENP1), designed to enhance tumor radiosensitivity. | |||
T40067 | SENP1-IN-4 | SENP1-IN-4 | |
SENP1-IN-4, a distinct inhibitor of the deSUMOylation protease 1 (SENP1), is designed to enhance tumor radiosensitivity. | |||
T40069 | SENP1-IN-2 | SENP1-IN-2 | |
SENP1-IN-2, a distinct inhibitor of the deSUMOylation protease 1 (SENP1), is designed to enhance tumor radiosensitivity. | |||
T40066 | SENP1-IN-3 | SENP1-IN-3 | |
SENP1-IN-3 is a distinct inhibitor of the deSUMOylation protease 1 (SENP1), designed to enhance tumor radiosensitivity. | |||
T22168 | Vialinin A | Terrestrin A | DUB |
Vialinin A (Terrestrin A), a p-terphenyl compound, exhibits antioxidant properties and acts as a potent inhibitor of TNF-α, USP4, USP5, and sentrin/SUMO-specific protease 1 (SENP1). Its efficacy in autoimmune diseases an... | |||
T4S0181 | Hinokiflavone | MMP , BCL , E1/E2/E3 Enzyme | |
Hinokiflavone, a novel modulator of pre-mRNA splicing activity both in vitro and in cellulo, inhibits the assembly of the spliceosome, particularly blocking the formation of the B complex. Additionally, it acts as a SUMO... | |||
T64229 | SENP2-IN-1 | ||
SENP2-IN-1 is a selective inhibitor of SENP2. SENP2-IN-1 inhibits SENP1 (IC50: 1.3 μM), SENP2 (IC50: 0.69 μM) and SENP5 (IC50: 22.7 μM). SENP2-IN-1 can be used in cancer research. |